Jun 06,2022

Feel Therapeutics Receives Funding from SeedtoB Capital

Feel Therapeutics, a San Francisco, CA-based developer of digital biomarkers and therapeutics, raised an undisclosed amount in funding from SeedtoB Capital. The company intends to use the funds to accelerate their progress on the path to making data-driven mental health interventions accessible to those who need them.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 16,2023 TOP STORY

Lunit receives $150M capital chip-in, doubles down on US market

Shareholders of KOSDAQ-listed Lunit have recently participated in the company's recent capital raise, paying-in $150 million to fund its development of "next-generation" products and further expansion in the West. In a company disclosure, Lunit shared that more than a third or about $52 million of its capital proceeds will go to building new AI cancer diagnostics and therapeutics; $38 million will be invested in its subsidiaries in the United States and Europe; $30 million will be used to invest in external startups; and $15 million each will go to global talent and labour recruitment and acquiring patents, licences and other intangible assets. A day before it announced its significant capital raise, Lunit disclosed that it received the US FDA approval for its AI 3D Breast Tomosynthesis (DBT) solution.

FUNDING FUNDING ROUND

#ai/software

View Analyst & Ambassador Comments
Go to original news
Nov 09,2023 TOP STORY

Vida Health Announces $28.5 Million in Funding; Appoints Joe Murad CEO

Vida Health today announced it has closed $28.5 million in financing led by existing investors, including General Atlantic, Ally Bridge, Canvas Ventures, Hercules Capital, and other insiders. The company also named Joe Murad as Chief Executive Officer. Murad brings more than two decades of experience leading healthcare technology companies, with a demonstrated ability to guide venture-backed businesses from early stages through phases of significant growth. Murad succeeds Stephanie Tilenius, who will step down following nine years of service as Founder and CEO. Vida intends to use the investment to further scale and pursue ongoing growth opportunities, particularly in the rapidly expanding obesity and diabetes market.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 09,2023 TOP STORY

Vida Health Announces $28.5 Million in Funding; Appoints Joe Murad CEO

Vida Health today announced it has closed $28.5 million in financing led by existing investors, including General Atlantic, Ally Bridge, Canvas Ventures, Hercules Capital, and other insiders. The company also named Joe Murad as Chief Executive Officer. Murad brings more than two decades of experience leading healthcare technology companies, with a demonstrated ability to guide venture-backed businesses from early stages through phases of significant growth. Murad succeeds Stephanie Tilenius, who will step down following nine years of service as Founder and CEO. Vida intends to use the investment to further scale and pursue ongoing growth opportunities, particularly in the rapidly expanding obesity and diabetes market.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 18,2023

Poppins secures €8M for children's neurodevelopmental disorder therapy

Poppins (formerly known as Mila) has announced a €8 million financing round led by Eurazeo alongside Verve Ventures, Allianz France and HEC Ventures. This brings the company's funding to €12.9 million. Founded in 2018 and spun out of the École Polytechnique, the company is dedicated to the treatment of children's neurodevelopmental disorders, launching a therapeutic program for the families of children with specific "dys" learning difficulties, such as dyslexia, dysorthographia and dyscalculia. Poppins has created a digital therapy in the form of a musical video game downloadable to tablets or smartphones that can be used independently at home by children aged 7 to 11 with one or more specific learning disorders. A CE-marked digital medical device, the app is based on five years of scientific research carried out by engineers from the École Polytechnique and doctors and speech therapists from the teams at the La Timone hospital in Marseille, in close collaboration with the Fédération Française des DY.

FUNDING FUNDING ROUND

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 25,2021

Medical AI Provider Lunit Raises $61M in Funding Round Led By Major Global Healthcare Investors

Lunit, a leading medical AI provider, today announced it has raised $61 million in its Pre-IPO fundraising round ahead of the company’s planned public offering on the South Korean stock market (KOSDAQ) early next year. A number of new investors have joined the round including leading US healthcare investors HealthQuest Capital, Casdin Capital, and American Cancer Society BrightEdge, as well as Asia-based global healthcare investors Tybourne Capital Management, and NSG Ventures. HealthQuest Capital invested $20 million of the total funding amount. Prior to this latest round, Lunit closed a strategic investment of $26 million from Guardant Health last July. Combined with the pre-IPO round, the company has secured more than $135 million in total to date.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jan 01,2019

Lunit Grabs $4 Million from Fujifilm

Lunit, a leading medical artificial intelligence (AI) company providing solutions for precision diagnostics and therapeutics, announced today that it has raised $26M in its series C funding. This round was backed by Asian investors, led by Korea’s Shinhan Investment, followed by InterVest, IMM Investment, Kakao Ventures, and China’s Legend Capital of Lenovo Group. The funding round is the latest after the Fujifilm investment of $4.3M and Series B funding of $15M last year. Founded in 2013, Lunit has since raised $50M in total.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 04,2023

Smileyscope Closes Seed Prime Round

Smileyscope, an Austin, TX-based company advancing digital therapeutics, raised an undisclosed amount in Seed Prime funding. The round included investments from Breakthrough Victoria, Ten13, Alice Anderson Fund and MedAngels. The company intends to use the funds to grow its clinical-stage pipeline, and expand across the health systems in the United States and Australia.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 19,2023 TOP STORY

Outcomes4Me Announces Investments to Accelerate Life-Saving Treatments for Cancer Patients

 Outcomes4Me Inc., the developer of the direct-to-patient, personalized and evidence-based cancer navigation platform, announced today it has entered into two innovative collaborations and investment structures, which together combine artificial intelligence (AI) technology, treatment awareness and education, diagnostic testing access and mass media to help more patients with cancer. Through an equity investment and collaboration agreement with Labcorp, Outcomes4Me aims to improve patient outcomes by novel precision oncology treatment options through information about and access to specialty biomarker testing, including comprehensive genomic profiling, offered by Labcorp. Additionally, Outcomes4Me and Forecast Labs, a division of Comcast NBCUniversal, have entered into an earned equity investment arrangement to provide access to performance-based TV advertising to accelerate patient acquisition for Outcomes4Me. 

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Dec 23,2021

Danish medtech startup Hedia raises €3 million and plans European expansion

Medtech startup from Copenhagen, Hedia, has just raised an additional €3 million for its technology to manage diabetes. The company is backed by Novo-heirs, and we reckoned it was one to watch back in 2019.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING ROUND